Skip to content
10-Q

Quarterly Report

Celator Pharmaceuticals Inc

0001144204-15-048131

← back to feed
Filed
Aug 11, 2015 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2015 · Aug 10, 2015 33.8M sh
Capex Q2 2015 · Jun 30, 2015 $34.13K
Capex Q2 2015 · Jun 30, 2014 $4K
Long Term Debt Q2 2015 · Jun 30, 2015 $12.16M
Long Term Debt Q2 2015 · Dec 31, 2014 $9.84M
Short Term Debt Q2 2015 · Jun 30, 2015 $3.05M
Short Term Debt Q2 2015 · Dec 31, 2014 $284.96K
Cash And Equivalents Q2 2015 · Jun 30, 2015 $28.48M
Cash And Equivalents Q2 2015 · Dec 31, 2014 $32.41M
Cash And Equivalents Q2 2015 · Jun 30, 2014 $24.92M
Cash And Equivalents Q2 2015 · Dec 31, 2013 $23.59M
Stockholders Equity Q2 2015 · Jun 30, 2015 $13.38M
Stockholders Equity Q2 2015 · Dec 31, 2014 $21.91M
Current Liabilities Q2 2015 · Jun 30, 2015 $6.54M
Current Liabilities Q2 2015 · Dec 31, 2014 $3.29M
Total Liabilities Q2 2015 · Jun 30, 2015 $18.73M
Total Liabilities Q2 2015 · Dec 31, 2014 $13.21M
Current Assets Q2 2015 · Jun 30, 2015 $30.62M
Current Assets Q2 2015 · Dec 31, 2014 $33.57M
Total Assets Q2 2015 · Jun 30, 2015 $32.12M
Total Assets Q2 2015 · Dec 31, 2014 $35.12M
Sga Expense Q2 2015 · Jun 30, 2015 $2.01M
Sga Expense Q2 2015 · Jun 30, 2015 $3.78M
Sga Expense Q2 2015 · Jun 30, 2014 $1.73M
Sga Expense Q2 2015 · Jun 30, 2014 $3.62M
Rd Expense Q2 2015 · Jun 30, 2015 $3.45M
Rd Expense Q2 2015 · Jun 30, 2015 $6.16M
Rd Expense Q2 2015 · Jun 30, 2014 $2.94M
Rd Expense Q2 2015 · Jun 30, 2014 $5.9M
Net Income Q2 2015 · Jun 30, 2015 −$4.98M
Net Income Q2 2015 · Jun 30, 2015 −$9.69M
Net Income Q2 2015 · Jun 30, 2014 −$4.79M
Net Income Q2 2015 · Jun 30, 2014 −$9.07M
Operating Income Q2 2015 · Jun 30, 2015 −$4.48M
Operating Income Q2 2015 · Jun 30, 2015 −$8.86M
Operating Income Q2 2015 · Jun 30, 2014 −$4.58M
Operating Income Q2 2015 · Jun 30, 2014 −$8.85M